Otsuka and Click Therapeutics’ Rejoyn has become the first prescription digital therapeutic (DTx) to be approved by the FDA for people with major depressive disorder. Rejoyn (formerly CT-152), a ...
Two pioneering digital therapeutics (DTx) for addiction are available once again after their original developer Pear Therapeutics was dissolved last year. The two FDA-approved apps – RESET and ...
ETF trading exchanges have also received significant attention due to the increased demand for the instrument. DTX Exchange (DTX) is being noticed due to its highly efficient ETF trading facility, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback